These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23506699)

  • 1. Diabetic retinopathy: neuron protection as a therapeutic target.
    Zhang X; Wang N; Barile GR; Bao S; Gillies M
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1525-9. PubMed ID: 23506699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.
    Zafar S; Sachdeva M; Frankfort BJ; Channa R
    Curr Diab Rep; 2019 Feb; 19(4):17. PubMed ID: 30806815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for diabetic retinopathy.
    Imai H; Singh RSJ; Fort PE; Gardner TW
    Dev Ophthalmol; 2009; 44():56-68. PubMed ID: 19494653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy.
    Zhang X; Bao S; Hambly BD; Gillies MC
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2368-71. PubMed ID: 19646547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy.
    Wong TY; Cheung CM; Larsen M; Sharma S; Simó R
    Nat Rev Dis Primers; 2016 Mar; 2():16012. PubMed ID: 27159554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
    Kadłubowska J; Malaguarnera L; Wąż P; Zorena K
    Curr Neuropharmacol; 2016; 14(8):831-839. PubMed ID: 27306035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin replacement: a new strategy for treating diabetic retinopathy.
    Hernández C; Simó R;
    Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.
    Chakravarthy H; Devanathan V
    J Mol Neurosci; 2018 Nov; 66(3):445-461. PubMed ID: 30293228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration in diabetic retinopathy: Potential for novel therapies.
    Barber AJ; Baccouche B
    Vision Res; 2017 Oct; 139():82-92. PubMed ID: 28988945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
    Hernández C; Dal Monte M; Simó R; Casini G
    J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.
    Simó R; Hernández C
    Prog Retin Eye Res; 2015 Sep; 48():160-80. PubMed ID: 25936649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in the modulation of diabetic retinopathy.
    Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
    Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
    Soliman W; Hasler P; Sander B; Larsen M
    Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.
    Jindal V
    Mol Neurobiol; 2015; 51(3):878-84. PubMed ID: 24826918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.